Approval · Notice of Compliance 3713 · 1997
VOLTAREN RAPIDE: Notice of Compliance 3713
Issued May 15, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3713
- Date
- May 15, 1997
- Company
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Anti-inflammatory, analgesic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VOLTAREN RAPIDE | 00881635 | Marketed |
Medicinal ingredients
- DICLOFENAC POTASSIUM 50 MG per TAB